HONG KONG – The findings of new study by Chinese researchers have led to the discovery of a new means of increasing the anticancer activity of the immune system’s killer T cells by modifying cholesterol metabolism, which could be used to complement other current cancer immunotherapies, such as immune checkpoint blockade.